<DOC>
	<DOCNO>NCT02486289</DOCNO>
	<brief_summary>A randomize , placebo control , double blind proof concept study NBMI treatment mercury intoxication .</brief_summary>
	<brief_title>Pilot Proof Concept Study NBMI Treatment Mercury Intoxication</brief_title>
	<detailed_description>The objective study evaluate efficacy safety two dos NBMI compare placebo mercury intoxicate patient .</detailed_description>
	<mesh_term>Poisoning</mesh_term>
	<mesh_term>Mercury Poisoning</mesh_term>
	<criteria>Inclusion criterion 1 . Male female subject , age 18 65 year , inclusive . 2 . UrineHg ≥ 15 μg/L . 3 . Mercury intoxication medical score sum ( Doering et al . 2014 ) ≥ 5 medical score sum ≥ 3 combination least two follow symptom ; social nervousness/withdrawal , irritability , memory loss , metallic taste , mental physical fatigue . 4 . Has sign inform consent participation . 5 . Willingness ability comply study procedure , visit schedule , instruction regard study . Exclusion criteria 1 . History clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result subject 's ability participate study . 2 . Known medical history renal disorder , significant renal failure , high risk renal failure . 3 . Any clinically significant abnormality clinical chemistry haematology result time screen judge investigator . 4 . Known suspected neurodegenerative disorder include limited stroke , polio , Parkinson 's Alzheimer 's disease . 5 . Known suspected drug alcohol abuse . 6 . Positive pregnancy test woman . 7 . Serious bacterial chronic viral infection human immunodeficiency virus ( HIV ) hepatitis virus . 8 . History severe allergy/hypersensitivity ongoing allergy/hypersensitivity , judge investigator history hypersensitivity drug similar chemical structure class NBMI . 9 . History allergy/hypersensitivity bisulphites ( e.g . red/white wine ) . 10 . Participation clinical study include drug treatment within three month first administration investigational product . 11 . Use therapies mercury intoxication include metal chelators within three month . 12 . Investigator considers subject unlikely comply study procedure , restriction requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Mercury toxicity poisoning</keyword>
</DOC>